Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and human leukocyte antigen associations

Liver Transplantation

Volumn 16, Issue 11, 2010, Pages 1324-1330

  Bowlus, Christopher L ^a   Li, Chin Shang ^b   Karlsen, Tom H ^c   Lie, Benedicte A ^c   Selmi, Carlo ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTERITIS; EUROPEAN AMERICAN; FEMALE; GENETIC VARIABILITY; HISPANIC; HLA SYSTEM; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ALLELES; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-B8 ANTIGEN; HLA-DR ANTIGENS; HUMANS; INFLAMMATORY BOWEL DISEASES; LINKAGE DISEQUILIBRIUM; LIVER DISEASES; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 78349269179     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22161     Document Type: Article

References (39)

1. Aron JH, Bowlus CL,. The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 2009; 31: 383 - 397.
2. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610 - 615.
3. Tischendorf JJ, Hecker H, Kruger M, Manns MP, Meier PN,. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007; 102: 107 - 114.
4. Kingham JG, Kochar N, Gravenor MB,. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004; 126: 1929 - 1930.
5. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559 - 1568.
6. Card TR, Solaymani-Dodaran M, West J,. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 2008; 48: 939 - 944.
7. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H,. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99 - 103.
8. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364 - 1369.
9. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E,. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 1994; 21: 787 - 791.
10. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY,. Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol 2002; 17: 908 - 913.
11. Parlak E, Kosar Y, Ulker A, Dagli U, Alkim C, Sahin B,. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey. J Clin Gastroenterol 2001; 33: 299 - 301.
12. Kochhar R, Goenka MK, Das K, Nagi B, Bhasin DK, Chawla YK, et al. Primary sclerosing cholangitis: an experience from India. J Gastroenterol Hepatol 1996; 11: 429 - 433.
13. Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, et al. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB113 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut 2002; 51: 609 - 610.
14. Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H,. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int 2008; 28: 983 - 989.
15. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort. Am J Gastroenterol 2006; 101: 1012 - 1023.
16. Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010; 138: 1102 - 1111.
17. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160 - 167.
18. Lumeng L, Crabb DW,. Genetic aspects and risk factors in alcoholism and alcoholic liver disease. Gastroenterology 1994; 107: 572 - 578.
19. Stephens M, Smith NJ, Donnelly P,. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978 - 989.
20. Nguyen GC, Thuluvath PJ,. Racial disparity in liver disease: biological, cultural, or socioeconomic factors. Hepatology 2008; 47: 1058 - 1066.
21. Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS,. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl 2004; 10: 834 - 841.
22. Bergquist A, Said K, Broome U,. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Scand J Gastroenterol 2007; 42: 88 - 93.
23. Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ III, Sandborn WJ,. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254 - 261.
24. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S,. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24: 38 - 41.
25. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E,. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982; 17: 187 - 191.
26. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R,. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129 - 133.
27. Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT,. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 1998; 28: 660 - 662.
28. Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 2001; 120: 1475 - 1482.
29. Wiencke K, Spurkland A, Schrumpf E, Boberg KM,. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 2001; 34: 625 - 630.
30. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, et al. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001; 49: 288 - 294.
31. Candore G, Lio D, Colonna Romano G, Caruso C,. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002; 1: 29 - 35.
32. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257 - 274.
33. Jakobsson M, Scholz SW, Scheet P, Gibbs JR, VanLiere JM, Fung HC, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 2008; 451: 998 - 1003.
34. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF,. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006; 79: 640 - 649.
35. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999; 53: 459 - 469.
36. Donaldson PT, Norris S,. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002; 35: 555 - 564.
37. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL,. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997; 64: 1017 - 1027.
38. Leffell MS, Cherikh WS, Land G, Zachary AA,. Improved definition of human leukocyte antigen frequencies among minorities and applicability to estimates of transplant compatibility. Transplantation 2007; 83: 964 - 972.
39. Zachary AA, Bias WB, Johnson A, Rose SM, Leffell MS,. Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: part 1, African-Americans. Hum Immunol 2001; 62: 1127 - 1136.